Upstream Bio will use its IPO haul to continue clinical testing of verekitug, which it contends could be a better treatment option for severe asthma compared to a commercialized Amgen and ...

£;Ã0 ae¥ÖCªHÍê P ‰1nè _ þýU`ìnˆu\Ï÷¥~æÿÇ3U7ÈûbëX–Mðó J {ôYK¶´«»#ïÖ)ïÖ H4IH @ àÌкªr ¼o’¼$xQèÕ–ýŸ®Öô/­ä ÛYHü ...

Higher doses of a Viking Therapeutics pill that targets two receptors led to greater weight loss without worsening safety or tolerability, according to Phase 1 results presented during the ...